Effectiveness of the probiotic Streptococcus salivarius K12 for the treatment and/or prevention of sore throat: a systematic review.
- 2019-06
- Systematic Review
- Clinical Microbiology and Infection 25(6)
- C. Wilcox
- C. Wilcox
- B. Stuart
- Hannah Leaver
- M. Lown
- M. Willcox
- Michael Moore
- P. Little
- PubMed: 30616011
- DOI: 10.1016/j.cmi.2018.12.031
- High evidence
- Rigorous Journal
One compared daily administration of SsK12 to no treatment over 6 months (n = 222, age 33-45 months), reporting significantly lower incidence in the SsK12 group (16.2% vs. 48.6%, p < 0.01)
- Effect
- Beneficial
- Effect size
- Large
- Significant
- No